Education
About Us
Working with TipRanks
Follow Us
Strata Skin Sciences (SSKN)
:SSKN
Total Valuation
Strata Skin Sciences has a market cap or net worth of $7.59M. The enterprise value is $19.94M.
Market Cap$7.59M
Enterprise Value$19.94M
Share Statistics
Strata Skin Sciences has 4,171,161 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,171,161
Owned by Insiders3.91%
Owned by Institutions23.26%
Financial Efficiency
Strata Skin Sciences’s return on equity (ROE) is -2.03 and return on invested capital (ROIC) is -41.64%.
Return on Equity (ROE)-2.03
Return on Assets (ROA)-0.28
Return on Invested Capital (ROIC)-41.64%
Return on Capital Employed (ROCE)-0.43
Revenue Per Employee316.62K
Profits Per Employee-95.15K
Employee Count106
Asset Turnover0.93
Inventory Turnover6.45
Valuation Ratios
The current PE Ratio of Strata Skin Sciences is ―. Strata Skin Sciences’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value22.28
Price to FCF―
Price to Operating Cash Flow-36.12
PEG Ratio―
Income Statement
In the last 12 months, Strata Skin Sciences had revenue of 33.56M and earned -10.09M in profits. Earnings per share was -0.26.
Revenue33.56M
Gross Profit19.08M
Operating Income-9.26M
Pretax Income-10.26M
Net Income-10.09M
EBITDA-2.84M
Earnings Per Share (EPS)-0.26
Cash Flow
In the last 12 months, operating cash flow was -2.09M and capital expenditures -704.00K, giving a free cash flow of -2.79M billion.
Operating Cash Flow-2.09M
Free Cash Flow-2.79M
Free Cash Flow per Share-0.67
Dividends & Yields
Strata Skin Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.12
52-Week Price Change-35.14%
50-Day Moving Average2.16
200-Day Moving Average2.64
Relative Strength Index (RSI)35.18
Average Volume (3m)34.96K
Important Dates
Strata Skin Sciences upcoming earnings date is Nov 18, 2025, After Close (Confirmed).
Last Earnings DateAug 13, 2025
Next Earnings DateNov 18, 2025
Ex-Dividend Date―
Financial Position
Strata Skin Sciences as a current ratio of 1.13, with Debt / Equity ratio of 351.62%
Current Ratio1.13
Quick Ratio0.98
Debt to Market Cap0.14
Net Debt to EBITDA-3.23
Interest Coverage Ratio-4.39
Taxes
In the past 12 months, Strata Skin Sciences has paid -170.00K in taxes.
Income Tax-170.00K
Effective Tax Rate0.02
Enterprise Valuation
Strata Skin Sciences EV to EBITDA ratio is -42.21, with an EV/FCF ratio of -82.85.
EV to Sales3.57
EV to EBITDA-42.21
EV to Free Cash Flow-82.85
EV to Operating Cash Flow638.12
Balance Sheet
Strata Skin Sciences has $5.97M in cash and marketable securities with $1.08M in debt, giving a net cash position of -$4.88M billion.
Cash & Marketable Securities$5.97M
Total Debt$1.08M
Net Cash-$4.88M
Net Cash Per Share-$1.17
Tangible Book Value Per Share-$0.08
Margins
Gross margin is 57.89%, with operating margin of -27.58%, and net profit margin of -30.05%.
Gross Margin57.89%
Operating Margin-27.58%
Pretax Margin-30.56%
Net Profit Margin-30.05%
EBITDA Margin-8.47%
EBIT Margin-24.28%
Analyst Forecast
The average price target for Strata Skin Sciences is $2.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$2.75
Price Target Upside53.63% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast0.36%
EPS Growth Forecast-17.20%